<DOC>
	<DOCNO>NCT01778686</DOCNO>
	<brief_summary>The serotonin 2A ( 5-HT2A ) receptor abundant excitatory serotonin ( 5-HT , 5-hydroxytryptamine ) receptor human brain , multiple positron emission tomography ( PET ) study investigate 5-HT2A receptor human brain use antagonist radioligands . However , currently available antagonist PET radioligands bind total pool 5-HT2A receptor receptor whereas 5-HT2A receptor agonist bind high-affinity subgroup receptor also G-protein couple , thus hypothesize functional relevant population receptor . At Center Integrated Molecular Brain Imaging ( CIMBI ) , novel agonist PET radioligands brain image 5-HT2A receptor recently validate animal ( Ettrup et al . 2011 , EJNMMI ) . In human brain , [ 11C ] Cimbi-36 validate selective 5-HT2A receptor agonist PET radioligand block study 5-HT2A receptor antagonist pharmaceutical ketanserin . In validation study , biodistribution kinetic modelling [ 11C ] Cimbi-36 binding human brain also validate . With study , investigator test promising , [ 11C ] Cimbi-36 , clinical trial , provide novel method detect dysfunction 5-HT system . The specific aim clinical trial : - To examine effect acute alteration 5-HT level cerebral [ 11C ] Cimbi-36 binding healthy volunteer PET-scanned baseline pharmacological dietary intervention either increase decrease cerebral 5-HT level . It hypothesize novel agonist radioligand provide physiological relevant measure 5-HT2A receptor also reflect level cerebral 5-HT human , specifically : BP decrease pindolol selective serotonin reuptake inhibitor ( SSRI ) treatment increase acute tryptophan depletion ( ATD ) . Placebo leave bind potential ( BP ) unchanged .</brief_summary>
	<brief_title>Evaluation 11CCimbi-36 Agonist PET Radioligand Imaging 5-HT2A Receptors</brief_title>
	<detailed_description />
	<mesh_term>Pindolol</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<mesh_term>Tryptophan</mesh_term>
	<criteria>Age &gt; 18 year Generally healthy primary psychiatric disorder current previous neurological disease , severe somatic disease take medication influence result . nonfluent danish severe visual hearing impairment current previous learn difficulty pregnancy lactate contraindication magnetic resonance scan alcohol drug abuse allergy use medication participation study radioactivity ( &gt; 10 mSv ) within last year significant occupational exposure radioactivity .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Positron Emission Tomography</keyword>
	<keyword>Serotonin</keyword>
	<keyword>5-HT2A</keyword>
	<keyword>Radioligand</keyword>
</DOC>